Skip to content

Clinical trials

Completed Hematologic Diseases trials in Taiwan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hematologic Diseases Status: Completed Country / region: Taiwan Clear all

15 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20101
20121
20131
20141
20151
20171
20185
20191
20203

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed15

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
BioMarin Pharmaceutical3
Abbott Medical Devices2
Genzyme, a Sanofi Company2
Amgen1
Celgene1
National Taiwan University Hospital1
Novartis Pharmaceuticals1
Pfizer1
Seagen Inc.1
Sierra Oncology LLC - a GSK company1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hematologic Diseases15
Blood Coagulation Disorders5
Blood Coagulation Disorders, Inherited5
Bone Marrow Diseases5
Coagulation Protein Disorders5
Genetic Diseases, Inborn5
Hemophilia A5
Hemorrhagic Disorders5
Hemostatic Disorders5
Neoplasms4

Trials

Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.